AG
AGN

Aperio Group’s Allergan plc AGN Stock Holding History

Aperio Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-183,530
Closed -$32.5M – 2431
2020
Q1 		$32.5M Buy
183,530
+30,427
+20% +$5.73M 0.14% 151
2019
Q4 		$29.3M Buy
153,103
+13,907
+10% +$2.51M 0.11% 208
2019
Q3 		$23.4M Buy
139,196
+57,812
+71% +$9.42M 0.09% 245
2019
Q2 		$13.6M Sell
81,384
-39,791
-33% -$5.51M 0.06% 379
2019
Q1 		$17.7M Buy
121,175
+29,413
+32% +$4.26M 0.08% 289
2018
Q4 		$12.3M Sell
91,762
-57,555
-39% -$9.43M 0.06% 343
2018
Q3 		$28.4M Buy
149,317
+35,365
+31% +$6.5M 0.13% 179
2018
Q2 		$19M Buy
113,952
+8,651
+8% +$1.39M 0.09% 253
2018
Q1 		$17.7M Buy
105,301
+16,561
+19% +$2.78M 0.09% 265
2017
Q4 		$14.5M Sell
88,740
-40,298
-31% -$7.23M 0.07% 313
2017
Q3 		$26.4M Sell
129,038
-5,220
-4% -$1.21M 0.15% 157
2017
Q2 		$32.6M Buy
134,258
+13,508
+11% +$3.17M 0.2% 108
2017
Q1 		$28.9M Buy
120,750
+37,102
+44% +$8.64M 0.2% 108
2016
Q4 		$17.6M Sell
83,648
-45,016
-35% -$9.33M 0.13% 168
2016
Q3 		$29.6M Buy
128,664
+23,562
+22% +$5.76M 0.21% 106
2016
Q2 		$24.3M Sell
105,102
-6,578
-6% -$1.52M 0.19% 122
2016
Q1 		$29.9M Sell
111,680
-2,582
-2% -$739K 0.26% 83
2015
Q4 		$35.7M Buy
114,262
+11,962
+12% +$3.56M 0.33% 62
2015
Q3 		$27.8M Buy
102,300
+12,622
+14% +$3.88M 0.28% 74
2015
Q2 		$27.2M Sell
89,678
-2,972
-3% -$886K 0.28% 79
2015
Q1 		$27.6M Buy
92,650
+47,680
+106% +$13.6M 0.31% 66
2014
Q4 		$11.6M Buy
44,970
+7,034
+19% +$1.76M 0.14% 169
2014
Q3 		$9.15M Buy
37,936
+9,850
+35% +$2.2M 0.12% 201
2014
Q2 		$6.26M Buy
28,086
+2,625
+10% +$544K 0.09% 277
2014
Q1 		$5.24M Buy
+25,461
New +$5.04M 0.07% 347
2013
Q4 		– Sell
-18,847
Closed -$2.95M – 418
2013
Q3 		$2.71M Buy
18,847
+2,594
+16% +$346K 0.05% 471
2013
Q2 		$2.05M Buy
+16,253
New +$1.84M 0.05% 497

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Aperio Group's AGN Position: Q2 2020 in Review

Aperio Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 183,530 shares — an estimated $32.5M sold.

Aperio Group first reported a position in AGN in Q2 2013 and held it in 27 quarters. The position peaked at $35.7M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Aperio Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Aperio Group sold 183,530 Allergan plc shares in Q2 2020, an estimated $32.5M.
  • Aperio Group first reported a position in Allergan plc in Q2 2013 and held it in 27 quarters.
  • Aperio Group's Allergan plc position peaked at $35.7M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Aperio Group's 13F filing for Q2 2020, filed 13 Aug 2020.